Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,822
Total Claims
$585K
Drug Cost
737
Beneficiaries
$794
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+10%
Cost per patient vs peers
$794 vs $719 avg
+6%
Brand preference vs peers
7.0% vs 6.7% avg
Brand vs Generic
Brand: 756 claims · $439K
Generic: 10,004 claims · $145K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 39 | $57K |
| Apixaban | 43 | $55K |
| Semaglutide | 31 | $51K |
| Dulaglutide | 30 | $37K |
| Insulin Detemir | 31 | $32K |
| Sitagliptin Phosphate | 21 | $29K |
| Rivaroxaban | 22 | $20K |
| Fluticasone/Umeclidin/Vilanter | 11 | $18K |
| Fluticasone/Vilanterol | 17 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 12 | $11K |
| Atorvastatin Calcium | 559 | $7,506 |
| Levothyroxine Sodium | 420 | $5,336 |
| Potassium Chloride | 102 | $4,712 |
| Omeprazole | 307 | $4,467 |
| Gabapentin | 427 | $3,918 |
Prescribing Profile
Patient Profile
73
Avg Age
57%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data